Chronic spontaneous urticaria

• Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria. Pending
  2024-518786-10-01 4 "Moderate to Severe Chronic Spontaneous Urticaria"
• A clinical trial to provide continued access to remibrutinib (LOU064) for people who are benefiting from it in a previous remibrutinib trial Pending
  2025-524078-40-00 5 "Chronic Spontaneous Urticaria"
• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting
  2025-522878-36-00 5 2026-04-20 "Chronic Spontaneous Urticaria"
• Tildrakizumab, an Anti-IL-23 Antibody for the Treatment of Refractory Chronic Spontaneous Urticaria – a single-arm, open-label, phase II stu … Recruiting
  2024-513155-32-00 4 2026-03-02 "chronic spontaneous urticaria"
• A Phase 2 Study of Lesigercept (YH35324) in Adult Patients with Chronic Spontaneous Urticaria (CLEAR) Recruiting
  2025-524006-14-00 4 2026-04-20 "Chronic Spontaneous Urticaria"
• A Study to Learn About the Study Medicine Called Ritlecitinib in People With Hives Without a Known Cause Recruiting
  2025-522642-44-00 4 2026-03-18 "CHRONIC SPONTANEOUS URTICARIA"
• 24 weeks double-blind randomized placebo-controlled trial to evaluate efficacy, PK, safety of LOU064 in adolescents (12 - <18) with CSU and … Recruiting
  2022-502159-78-00 5 2023-12-06 "Chronic Spontaneous Urticaria"
• A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Recruitment ended
  2024-513210-36-00 5 2025-04-04 "Chronic Spontaneous Urticaria"
• A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Recruitment ended
  2024-513208-32-00 5 2024-12-16 "Chronic Spontaneous Urticaria"
• Effect of briquilimab in patients with patches of itching skin because of chronic spontaneous urticaria (CSU) despite treatment with antihis … Recruitment ended
  2023-505446-25-00 9 2024-03-20 "Chronic Spontaneous Urticaria"
• 52 weeks double-blind, double-dummy, randomized placebo-controlled trial to evaluate safety, efficacy and tolerability of remibrutinib in co … Recruitment ended
  2022-502161-19-00 5 2024-03-12 "Chronic Spontaneous Urticaria"
• An extension study of long-term efficacy, safety and tolerability of remibrutinib in chronic spontaneous urticaria patients who completed pr … Recruitment ended
  2024-510818-33-00 5 2023-01-24 "Chronic Spontaneous Urticaria"
• Open-label basket study for safety and pharmacokinetics evaluation of INF904 in subjects with CSU or HS Ended
  2024-515615-22-00 4 2025-04-02 "Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Mo"
• This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adu … Ended
  2023-504799-94-00 4 2024-02-20 "Chronic Spontaneous Urticaria"
• A study to investigate the pharmacokinetics of remibrutinib in CSF in healthy participants. Ended
  2023-506760-13-00 3 2023-12-11 "Healthy"
• Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria Ended
  2022-503062-72-00 4 2023-11-23 "Chronic Spontaneous Urticaria"
• BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria Ended
  2024-514764-72-00 5 2023-09-27 "Chronic Urticaria"
• Proof of concept study to assess the efficacy and safety of Danicopan (factor D inhibitor) in adult patients with chronic spontaneous urtica … Ended
  2024-512386-14-00 4

Showing 1–18 of 18 trials